Skip to content

Have your say – MHRA’s public consultation on proposals for legislative changes for clinical trials

Date: January 26, 2022

Dear Colleague,

We have just launched our 8-week public consultation on proposals for legislative changes for clinical trials.

We want to streamline clinical trial approvals, enable innovation, enhance clinical trials transparency, enable greater risk proportionality, and promote patient and public involvement in clinical trials.

We would like to hear from clinical trial participants, researchers, developers, manufacturers, sponsors, investigators, healthcare professionals and the wider public to help shape improvements to the legislation for clinical trials.

You can read more about our proposals in our Press release and consultation document. 

Please do share this email and the social media links below with your networks and contacts so that we can get the broadest possible response. 

The consultation will close at 11pm on Monday, 14 March 2022.

Thank you for your support.

The Medicines and Healthcare products Regulatory Agency

https://www.gov.uk/government/consultations/consultation-on-proposals-for-legislative-changes-for-clinical-trials

 


 

Explore More News

Welcome P95 as a corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome P95 as a new . . .

Read More

AI Symposium Session Summary: Is AI in clinical trials delivering measurable ROI?

At the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, the . . .

Read More

Newsletter Committee: Meet Neha

The ACDM is delighted to welcome Neha Shah of ITM to the Newsletter Committee. Neha shares . . .

Read More

Newsletter Committee: Meet Sylvain

The ACDM is delighted to welcome Sylvain Berthelot of CRScube to the Newsletter . . .

Read More

Welcome VHypotenuse as a corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome VHypotenuse as . . .

Read More

Newsletter Committee: Meet Marta

The ACDM is delighted to welcome Marta Kowalska of CluePoints to the Newsletter . . .

Read More

AI model trained on de-identified data from 57 million people

Researchers at UCL have trained an AI model using de-identified data from 57 million . . .

Read More

ACDM Regulatory Considerations DMEG Update: ICH E6 (R3) GCP Final Publication Released

The final publication of ICH E6 (R3) Good Clinical Practice (GCP) General Principles and . . .

Read More

ICH E6(R3) Guideline reaches Step 4 of the ICH Process

ICH E6(R3) reaches Step 4 of the ICH Process on 6th January 2025. The guideline . . .

Read More

U.S. Food & Drug Administration: Draft Guidance for Industry and Other Interested Parties

The U.S. Food and Drug Administration has issued its first guidance on the use of . . .

Read More

ACDM DMEG News: Regulatory Updates and Forthcoming Challenges for 2025

As 2024 draws to a close, the Regulatory Considerations Data Management Expert Group . . .

Read More

Audit Trail Review DMEG Update – New Guide

The Audit Trail Review (ATR) DMEG has been hard at work putting the finishing touches on a . . .

Read More